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ABSTRACT 
 
Effects of Acetaminophen on Estrogen-Responsive Alkaline Phosphatase Activity 
 in Ishikawa Endometrial Cancer Cells 
 
 
Janet A. Dowdy 
 
 
This study examines the effect of acetaminophen (APAP) on the estrogen-responsive 
gene alkaline phosphatase in Ishikawa endometrial cancer cells. Basal levels of alkaline 
phosphatase activity were significantly inhibited in cells treated with 0.03, 0.1, 0.3 and 1mM 
APAP compared to control. Alkaline phosphatase activity induced with 1nM estradiol was 
significantly inhibited in a concentration dependent manner by 0.0.1, 0.3 and 1mM APAP. 
APAP did not directly inhibit the activity of alkaline phosphatase at any of the concentrations 
tested. Increasing estradiol concentrations (0.01, 0.1 and 1nM) did not alter the level of inhibition 
of alkaline phosphatase activity by 0.1, 0.3 or 1mM APAP. This is in agreement with other 
studies, which have concluded that APAP does not compete with estradiol for binding at the 
estrogen receptor (Harnagea-Theophilusa et al., 1999; Isenhower et al., 1986; Miller et al., 
1999). Protein concentrations were significantly decreased in Ishikawa cells with 0.3 and 1mM 
APAP alone or in the presence of 0.01, 0.1 to 1nM estradiol. Inhibition of alkaline phosphatase 
activity by high levels (0.3 and 1mM) of APAP may be in part due to toxic effects of APAP as 
determined by LDH release. Fluorescent microscopy using calcein staining techniques show that 
Ishikawa cells treated with 1nM E2+0.3mM APAP are visibility misshapen; cells treated with 
1nM E2+1mM APAP are no longer attached to the plate indicating toxicity. The final part of this 
study looked at the interaction between antiestrogen-4-hydroxy tamoxifen (OHT) and APAP on 
alkaline phosphatase activity in Ishikawa cells. While OHT inhibited alkaline phosphatase 
activity ~50 percent in estradiol-induced cells, addition of 0.03-1mM APAP increased inhibition 
significantly in a concentration dependent manner. Results of this study indicate that APAP 
decreases estrogen-responsive alkaline phosphatase activity in Ishikawa cells in vitro, and that 
this inhibition is not attributed to direct inhibition of enzyme activity.
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 1 
Introduction 
Endocrine Disrupters and Acetaminophen 
 
Endocrine Disrupters (EDs) are exogenous agents that interfere with the synthesis, 
secretion, transport, binding or elimination of natural hormones in the body. Although most 
known EDs, such as 1,1,1-trichloro-2,2-bis(p-chlorophenyl) ethane (DDT), have estrogen-like 
activity, it is possible for EDs to possess antagonist activity or to cross talk between different 
endocrine pathways. The significance of alterations to endocrine processes includes disruption in 
hormone-mediated functions such as maintenance of homeostasis, reproduction, development, 
and/or behavior. Wildlife studies have shown the impact of EDs, such as DDT and 
polychlorinated biphenyls (PCBs), upon animal populations. Effects of these environmental EDs 
upon the human population are inconclusive, yet the worldwide increases in reproductive organ 
cancers (Brasso et al., 1999; Giwercman et al., 1993; Hill et al., 1983; Murphy et al., 1999; Sant 
1999 et al., Wingo et al., 1998), ectopic pregnancies (Rajkhowa et al., 2000), male urogential 
malformations (Weidner et al., 1998; Paulozzi et al., 1997), and decreased sperm count (Swan et 
al., 1999) cause concern that EDs may be impacting human health.  
Acetaminophen (APAP), a commonly used analgesic/antipyretic, is currently being 
investigated as a possible xenoestrogen. APAP contains a p-hydroxyl group and lipophylic 
conjugated six-member ring structure like estradiol (Cunningham et al., 1997). In vitro studies 
have shown that acetaminophen has the ability to induce estrogen-mediated DNA synthesis and 
cell proliferation in estrogen receptor positive (ER+) breast cancers cells (Harnagea-Theophilus 
et al., 1998) and inhibits estradiol-induced vitellogenin production in trout liver cells (Miller et 
al., 1999). Although no estrogenic activity was observed in uterotropic bioassays (Harnagea-
Theophilusb et al., 1999, Isenhower et al., 1986), animal studies have shown that APAP reduced 
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the number of litters per breeding pair, increased abnormal sperm counts and increased testicular 
atrophy in mice (Boyd et al., 1970, Reel et al., 1992). Even more significant are case studies 
indicating that APAP has endocrine altering effects in the human population such as lowering 
basal hormone levels in women (Cramerb et al., 1998) and reducing the risk of ovarian cancer 
(Cramera et al., 1998). In combination, these studies suggest that APAP is impacting endocrine 
function not only in in vitro and animal studies but also within the human population taking this 
drug.  
 
Wildlife Studies 
 
Environmental contaminants have posed a threat to wildlife since the beginning of the 
industrial age. The theory that environmental pollutants, such as organochlorine pesticides and 
industrial waste, could have endocrine disrupting effects is a newer concern. The 1979 National 
Institute of Health’s “Estrogens in the Environment” symposium was the beginning of 
investigation into the endocrine disrupting potential of man-made chemicals being released into 
the environment (Guilleteb et al., 1995; McLachlan et al., 1992)(Fig.1). The connection between 
wildlife health effects and environmental exposure to endocrine disrupting chemicals has been 
well established. In addition, laboratory studies have shown that xenobiotics with estrogenic 
activity significantly alter both embryonic development and adult reproductive function in 
different animal models. The significance of these studies must be addressed to fully understand 
the impact that xenobiotic exposure could have upon the human population. 
Effects of Xenobiotics in Reptiles and Amphibians 
 
Aquatic animals are exposed to chemical pollutants dermally, orally, and through the 
food chain. While most environmental contamination occurs due to agricultural and urban use of 
pesticides, industrial waste is also a significant source and can pose a serious threat to wildlife. 
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One such example is the chemical spill by the Tower Chemical Company at Lake Apopka, 
Florida in 1980 (Semenza et al., 1997). That extensive chemical spill, which consisted mostly of 
difocal and DDT, led to registration of the lake as an EPA Superfund contamination site 
(Guillette et al., 1994). By 1994 the American alligator (Alligator mississippiensis) population at 
Lake Apopka had fallen to one tenth of its original number since 1970 and elevated levels of 
p,p’-DDE were found in the alligator eggs collected from the lake between 1984-85 (Guillette et 
al., 1994; Jennings et al., 1998, Woodward et al., 1989).  
While poor egg viability could not be directly correlated to the elevated organochlorine 
levels (Heinz et al., 1991), the observed concentrations (5.8ppm wet weight) were known to 
cause adverse effects in avian embryos (Cooper et al., 1991). Juvenile alligators obtained as eggs 
from Lake Apopka had significantly increased serum levels of p,p’-DDE, dieldrin, endrin, mirex, 
oxychlordane, DDTs, and PCBs compared to juveniles from uncontaminated Florida lakes 
(Guillette et al., 1999). However, the most disturbing aspect of these studies indicated changes in 
gonad morphology in both male and females alligators as well as changes in plasma sex steroid 
levels. Guillette reported that female alligators had plasma estrogen levels two times higher than 
normal along with the abnormal formation of ovaries. Male alligators had plasma testosterone 
levels three times lower than normal, malformed testes, and decreased phallus size (Guillette et 
al., 1996).  
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Fig.1. Structures of estradiol, DES and suspected xenoestrogens 
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In vitro studies examining steroidogenic activity of gonadal tissue from juvenile 
alligators showed changed in estradiol synthesis. Estrogen synthesis was increased in males and 
decreased in females; however, no significant differences in testosterone production were 
observed. Differences noted between steroid levels in vivo and in vitro studies may be explained 
by steroid synthesis and degradation processes that occur in the whole animal but not in in vitro 
studies (Guillettea et al., 1995). These studies support Guillette’s theory that chemicals spilled 
into Lake Apopka in 1980 have modified both reproductive and endocrine development 
permanently in resident alligators in ovo. 
Receptor binding studies have shown that some environmental chemicals possess the 
ability to bind alligator estrogen (aER) and alligator progesterone (aPR) receptors, which are 
present in the alligator oviduct (Vonier et al., 1997). p,p’-DDD and trans-nonaclor, both found in 
Lake Apopka following the chemical spill, interacted with aER while chlordane and toxaphene 
did not. However, when combined, these chemicals decreased [3H]-estradiol binding to aER in a 
greater than additive manner (Vonier et al., 1996). Chlordane, dieldren and toxaphene, which 
possess little appreciable estrogenic activity alone, in combination, act synergistically upon both 
alligator and human ER (Arnold et al., 1997).  
Temperature-dependent sex determination studies (TDS) show that estrogen has the 
ability to reverse effects of a male-producing temperature in red-eared slider turtles (Trachemys 
scripta) (Crews et al., 1995, Willingham et al., 1999) and alligators (Alligator mississippiensis) 
(Bull et al., 1980; Guillettea et al., 1995). In TDS, each egg has the potential to develop into a 
male or female as determined by the incubation temperature present at critical developmental 
periods. Temperature acts as a trigger to begin the cascade of biochemical events that lead to 
sexual development of one gender or the other. Sex steroids play an interactive role in TSD; 
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however, that role is not completely understood (Crews et al., 1995; Willingham et al., 1999). 
Xenobiotics suspected of being estrogenic were assayed at the concentrations found in alligator 
eggs from Lake Apopka. Those eggs incubated at a male-producing temperature with trans- and 
cis-Nonclor, aroclor 1242, p,p’-DDE or chlordane, alone or in combination, all produced 
significant sex reversal from male to female in red-eared slider turtles (Willingham et al., 1999). 
These studies demonstrate some of the more subtle effects that endocrine disrupting chemicals 
may have in reptile and amphibian populations. 
Xenoestrogens and Reproductive Failure in Birds 
 
Bioaccumulation of pesticides in predatory birds is a result of the widespread use, 
accumulation, and run-off of agricultural chemicals into aquatic environments. These 
contaminants are stored in the fatty tissue of fish and are consumed by predatory birds as well as 
other wildlife. Organochlorine pesticides, such as DDT, polychlorinated biphenols (PCBs), 
dioxins and dibenzofurans that have been identified as xenoestrogens, are linked to the 
reproductive failure in many avian species such as grebes (Rudd 1972), ospreys (Spitzer et al., 
1978), falcons (Cade et al., 1971), bald eagles (Cromartie et al., 1975) and cormorants (Ludwig 
et al., 1996). Due to the lipophylic nature of these contaminants, they are not only stored in the 
fat tissues of exposed birds but are, in addition, passed to their offspring by deposition into the 
yolks of their eggs (Fry et al., 1981). 
Avian embryos are especially sensitive to the effects of contaminants because they cannot 
be excreted and thus remain within the embryonic circulation throughout the incubation period. 
Metabolites of parent compounds can be more bioactive, as is the case of op’-DDT and 
methoxychlor, compounds which have been identified as weak xenoestrogens. Their 
hydroxylated metabolites have binding affinities almost equal to that of estradiol in estrogen 
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receptor binding studies (Bulger et al., 1978). In addition, many organochlorine compounds are 
inducers of chick embryo liver mixed-function oxidases (Rodman et al., 1991) and could 
possibly compound the level of estrogenic exposure by increasing the rate of metabolic 
activation of the weaker parent compound. 
Some effects of xenoestrogen exposure seen in birds are different than those found in 
mammals due to differences in steroid hormonal control during embryonic development. In 
contrast to mammals, male is the default sex in birds during sexual differentiation. Chick 
embryos differentiate from male to female only when estrogen is produced, resulting in the 
formation of the gonads into an ovary (Fry et al., 1995). Primordial germ cells (PGC), which 
migrate into the indifferent gonads during mid-gestation, by default end up in the seminiferous 
tubules in males (Romanoff et al., 1960). Estradiol induces development of the ovarian structure, 
regression of the right cortex and localization of PCG into the left cortex, which develops into an 
ovary (Fry et al., 1995). Gull eggs injected with op’-DDT or methoxychlor mimicked effects 
seen with estradiol or DES and developed abnormalities in both male and female embryos. Male 
embryos showed abnormal development of an oviduct or ovarian type tissue, and PGCs became 
localized in this ovarian-like tissue as well as in the seminiferous tubules. The right oviduct only 
partially regressed in females (Boss et al., 1947; Fry et al., 1987; Romanoff et al., 1960). DDT 
feminization has been associated with the inability of male gulls to breed and the high ratio of 
female to male gulls on Santa Barbara Island in Southern California (Fry et al., 1981).  
However, the most dramatic effect of DDT is eggshell thinning in exposed birds. While 
the inhibition of Ca2+-ATPase activity by DDT is well known, DDT also strongly inhibits the 
binding of progesterone and testosterone to their respective receptors located in the eggshell 
mucosal gland (Lunholm et al., 1991). In addition, DDT-induced eggshell thinning may be due 
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to an estrogenic effect. Hens exposed to estrogen as chicks produced defective, thin, or soft eggs 
in adulthood (Greenwood et al., 1938). Studies of Japanese quail exposed to DDT during 
embryonic development demonstrated not only increased eggshell malformations as adult hens, 
but also had long-term effects upon their reproductive behaviors (Bryan et al., 1989).  
 
Human Risk 
 
While the health effects of endocrine disruption upon wildlife have been well 
documented, the human risk is not as clearly defined. Human pathologies and disorders that may 
be related to EDs include increased incidence of: breast and female reproductive tract cancers 
(Hill et al., 1983; Sant et al., 1999; Wingo et al., 1998); prostate cancers (Brasso et al., 1999; 
Giwercman et al., 1993; Murphy et al., 1999); ectopic pregnancies (Rajkhowa et al., 2000); 
cryptorchidism and hypospadius (Paulozzi et al., 1997; Weidner et al., 1998); and a 50% 
decrease in sperm counts within the last 50 years (Swan et al., 1999). These trends in 
reproductive disorders and disease mimic the effects seen in both human diethylstilbestrol (DES) 
exposure and in studies of animals exposed to endocrine disrupting compounds. 
 
Diethylstilbestrol: An Example of Endocrine Disruption 
 
Diethylstilbestrol (DES) is an estrogenic drug that was used therapeutically from 1940-
1970 by approximately 6 million women worldwide to prevent habitual or spontaneous abortion. 
Adverse reactions to DES only appeared 12-15 years after exposure in the children of those 
women who took the drug during pregnancy. These side-effects range from infertility and 
reproductive tract anomalies to increased risk of rare cancers, and continue to appear in third 
generations (Dukes, 1996). In 1987, the Registry for Research on Hormonal Transplacental 
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Carcinogenesis reported that 60% of vaginal or cervical clear-cell carcinoma documented cases 
were in women who had been exposed to DES in utero. Exposed female children have a 30% 
probability of developing cervical vaginal adenosis during adolescence, which can develop into 
clear-cell adenocarcinoma. In addition to reproductive disorders, these women also have a 50% 
greater chance of developing autoimmune disease (Dukes, 1996). Exposed male children are at 
risk for a variety of reproductive disorders including cryptochordism, urethral abnormalities, 
epididymal cysts, testicular hypoplasia, decreased semen quality, and a doubled risk of 
developing testicular cancer (Toppari et al., 1996). DES case studies represent the only known 
data on the catastrophic effects of an estrogenic compound upon the human population.  
 10 
Effect of DES and Suspected Endocrine Disruptors in Animal Studies 
 
There have been extensive studies showing that prenatal DES exposure in rodents, at 
concentrations equivalent to the human therapeutic dose, produce similar effects upon fertility, 
reproductive tract development and function. Female mice exposed in utero had a dose-
dependent decrease in fertility, vaginal adenocarcinoma, cervical enlargement, cystic 
endometrial, ovarian tumors, and congenital malformations (McLachlan et al., 1980; Newbold et 
al., 1995). These reproductive tract lesions and fertility problems are very similar to those 
reported clinically in DES-exposed women. In rats, male offspring had a 5% risk of developing a 
rare testis cancer and a 92% risk of having retained testis or cryptochordism (Newbold et al., 
1995). As in the human exposure-effect, these reproductive anomalies are not always apparent in 
the offspring at birth. Male hamsters exposed to DES prenatally appeared normal at pubertal age, 
but as adults exhibited multiple lesions in reproductive tracts, spermatogenesis, cryptochordism 
and testicular tumors (Khan et al., 1998).  
Prenatal exposure to compounds suspected of causing endocrine disruptive activity, such 
as PCBs and phytoestrogens, have been shown to impact both reproductive system development 
and sexual behavior in male rats in the same manner as DES. Prenatal exposure to 4-octylphenol 
(OP), butyl benzyl phthalate (BBP), or Bis-phenol A all cause decreases in testicular size and 
sperm count (Sharpe et al., 1995; vom Saal et al., 1998). Phytoestrogens cause alterations in the 
development of the CNS-gonadal axis and male sexual behavior (Santti et al., 1998). In utero 
and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCCD) decreases plasma 
testosterone levels at birth and causes a permanent decrease in testicular size (Mably et al., 
1992). Chronic OP exposure of the adult animal decreases serum LH, FSH and testosterone 
(Blake et al., 1997), shrinkage of reproductive organs, and increases in sperm deformities 
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(Boockfor et al., 1997). Benzene-based dyes, antiandrogenic fungicides, TCCD and PCB 169 
exposure have all been correlated with abnormal rodent sex differentiation (Gray et al., 1999). 
Aroclor, as well as the chlorobiphenyl (CB) congeners CB47 and CB153, has shown estrogenic 
activity in female rat uterotropic studies (Soontornchat et al., 1994). 
 
Human exposure to Suspected Endocrine Disrupting Compounds 
 
Evidence of endocrine-disrupting effects upon the human population is complex, 
controversial and very limited. However, there are several studies examining the effects of PCBs 
upon human development and the relationship between organochlorines and development of 
breast cancer in women. 
  Prenatal PCB exposure through maternal consumption of contaminated fish from 
the Upper Great Lake Region increases the risk of lower birth weight, smaller head 
circumference (Fein et al., 1984), and decreased reflex and autonomic processing on the 
Neonatal Behavior Assessment Scale (NBAS) in the newborn (Lonky et al., 1996). Postnatal 
exposure through lactation most significantly decreased physical activity levels (Jacobson et al., 
1989). A follow up study of prenatally exposed 4-year-olds indicates that these children continue 
to have poor cognitive function in terms of short-term memory and processing speed (Jacobson 
et al., 1993). While estrogen receptor subtypes α and β are both expressed in various regions of 
the human brain (Beyer et al., 1999), their role in development of the central nervous system 
(CNS) is not completely understood. It is becoming more apparent that estrogen is important not 
only in sexual differentiation and reproductive neuroendocrine function, but also in neuron 
growth and differentiation (Toran-Allerand et al., 1999). Whether or not PCBs act with 
estrogenic activity upon the CNS during human fet al. development has yet to be determined. 
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Less conclusive studies have suggested that EDs may be responsible for higher male:female sex 
ratio of birth defects (urigenital / cardiovasculature / CNS) amongst pesticide appliers in 
Minnesota (Garry et al., 1996); significant alteration in the male:female ratio in occupational 
carbon setters (Milham et al., 1993), and permanent changes in sperm production in farm 
sprayers exposed to 2,4-dichlorophenoxyacetic acid (2,4-D) (Lerda et al., 1991). 
Environmental organochlorines, such as PCBs and DDE, are being investigated as 
possible risk factors in breast cancer of women. Case studies show that the cancerous breast 
tissue obtained from women has a 62% higher concentration of p,p’-DD and 25% increase in 
PCB118 (Guttes et al., 1998) compared to normal healthy tissue. Another study found that serum 
samples taken near the time of breast cancer diagnosis showed a positive correlation between the 
serum levels of PCB118, PCB 138, hexachlorobenzene, dieldrin and breast cancer incidence in 
women (Dorgan et al., 1999; Guttes et al., 1998; Hoyer et al., 1998). The New York University 
Women’s Health Study from 1985-1991 indicated that DDE increased breast cancer risk 4-fold 
while PCBs increased risk less than two-fold (Wolff et al., 1993). Other studies have found no 
correlation between serum organochlorine levels and incidence of breast cancer in women 
(Helzlsouer et al., 1999; Krieger et al., 1994). The contribution of organochlorines to the risk of 
the development of breast cancer is still controversial. However, the fact remains that 
organochlorines are present in significantly higher concentrations in the adipose tissue and serum 
of women in high-risk locations such as Long Island, New York (Stellman et al., 1998). Because 
of their prevalence in the environment, further investigation is necessary to discern the possible 
contribution of xenoestrogens to the development of breast cancer in women. 
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Acetaminophen 
Acetaminophen (APAP) is a widely used analgesic and antipyretic found in more than 
850 over-the-counter and prescription formulations (Prescott et al., 1996) (Fig.2.). APAP exerts 
its analgesic and antipyretic activity through selective inhibition of the cyclo-oxygenase 
isoenzyme in the central nervous system. APAP is a weak inhibitor of peripheral cyclo-
oxygenase and possesses only very weak anti-inflammatory effects (Welch and Martin 1995, 
Rang and Dale 1997). 
Fig.2. Structure of Acetaminophen 
NHCOCH3
OH
ACETAMINOPHEN
 
Acetaminophen metabolism (Fig.2.) occurs primarily in the liver where it is conjugated 
with glucuronide or sulfate and then readily excreted in the urine (Jollow 1973, 1974). Mixed-
function-oxidases (MFOs) can also metabolize APAP forming a highly reactive metabolite, N-
acetyl-p-benzoquinone (NAPQI), which is inactivated by binding to intracellular glutathione 
(Dahlin 1984). However, if the glutathione stores within the cell become depleted, such as in the 
case of APAP overdose, NAPQI will covalently bind to cysteine residues of cellular proteins as a 
3-(cystein-S-yl)-APAP adduct (Hinson 1980, Mitchell 1973). The depletion of glutathione due to 
certain disease states, such as liver cirrhosis or necrosis, also can lead to APAP toxicity due to 
NAPQI accumulation following chronic drug administration or high doses. In addition, 
individuals who may have induced P450 MFOs due to alcoholism or therapeutic drugs also run 
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the risk of toxicity due to increased metabolic production of NAPQI (Welch and Martin 1995). 
The site and amount of relevant covalent binding has been directly correlated with the 
development of APAP toxicity in humans and laboratory animals (Hinson et al., 1995; Ray et 
al., 2000). Administration of N-acetylcysteine decreases NAPQI covalent binding and its 
associated toxicity (Piperno et al., 1976). 
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Fig. 3. APAP Metabolism 
 
Acetaminophen has been shown to have various other effects upon cells in both in vitro 
and animal studies. At therapeutically relevant concentrations, APAP inhibits cell proliferation in 
HL-60 (Wiger et al., 1997), HepG2 (Dai et al., 1995), and V79 Chinese hamster cells (Holme et 
al., 1988); increases chromosomal breaks and inhibits DNA synthesis (Holme et al., 1988; 
Honglso et al., 1991); and down regulates c-myc and bcl-2 mRNA (Wiger et al., 1997). These 
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effects do not appear to be a result of formation of the toxic metabolite NAPQI as HepG2 (Dai et 
al., 1995) and V79 cells (Kappers et al., 2000) do not express endogenous P450 activity. 
In vitro studies in mouse and rat indicate that cytotoxic concentrations of APAP bind 
DNA, increase single strand breaks (SSBs), and interfere with DNA repair and synthesis 
(Honglso et al., 1994). In addition to hepatotoxicity (Tonge et al.,1998), high doses of APAP 
target mouse testis DNA synthesis resulting in decreased testicular weight, decreased number of 
spermatocytes, and deterioration in sperm chromatin structures (Wiger et al., 1995). 
Genotoxic effects are also apparent as chromosomal aberration in humans. In two of the 
three studies conducted with human volunteers taking a maximum daily dose of APAP (3 x 1000 
mg over 8-hours), there was a significantly higher frequency of chromatid breaks in peripheral 
lymphocytes 24 hours later (Hongslo et al., 1991).  
 
APAP as a Possible Endocrine Disrupter 
 
Recent studies have shown that APAP has the ability to alter estrogen responses in vitro 
in ER+ breast cancer cells. One study examined the effect of therapeutic concentrations of APAP 
upon estrogen-mediated DNA synthesis in ER+/PR+ and ER-/PR- breast cancer cells (Harnagea-
Theophilus et al., 1998). Proliferation was determined by [3H]-thymidine incorporation into 
DNA and percentage of cells in DNA synthesis (S) phase. While 0.1mM APAP was as effective 
as 3nM estradiol at promoting DNA synthesis in ER+/PR+ cells, the combination of APAP and 
estradiol was not additive. In addition, cell proliferation was not induced by estradiol or APAP in 
ER-/PR- breast cancer cells. 
Further studies examined the role of estrogen receptors (ER) in APAP-induced cell 
proliferation determined by [3H]-thymidine incorporation into DNA (Harnagea-Theophilusa et 
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al., 1999). APAP-induced cell proliferation in MCF7 and T47D (ER+/PR+) cells, but not in 
T47co (ER-/PR-) cells. Antiestrogens ICI 182,780 and 4’-hydroxytamoxifen, inhibited APAP 
induced proliferation in MCF7 and T47D (ER+/PR+) cells. Estrogen receptor binding studies 
were also performed in MCF7 (ER+/PR+) cells, and it was determined that APAP does not 
compete with estradiol for binding. The position of the -OH moiety on the benzene ring of APAP 
does appear to have an influence upon its ability to mimic estrogen-induced cell proliferation. 
Therapeutic plasma concentrations of APAP (0.1mM) induce varying amounts of breast cancer 
proliferation depending on the position of the -OH moiety p->m->o-acetaminophenol (Harnagea-
Theophilusb et al., 1999). These studies concluded that APAP was acting upon estrogen receptor-
mediated cell proliferation in a non-competitive manner with estradiol, and was inhibited by 
antiestrogens in ER+/PR+, but not in (ER-/PR-) breast cancer cells. The position of the 
hydroxyl-group influences potency of this activity. 
Acetaminophen’s estrogenic activity has been investigated in another estrogen-dependent 
process, the production of vitellogenin in isolated trout liver cells. Vitellogenin production is an 
absolutely estrogen-dependent process in trout liver cells. APAP caused a concentration-
dependent decrease of estrogen-induced vitellogenin mRNA and protein in trout liver cell in 
vitro studies. APAP (0.05mM) produced 50% inhibition of estradiol-induced vitellogenin 
production, while 0.3mM APAP reduced vitellogenin to undetectable levels. ER binding assays 
indicate that APAP does not reduce binding of [3H]-estradiol at the receptor (Miller et al., 1999). 
Acetaminophen also failed to show significant receptor binding in a soluble uterine receptor 
preparation or in an in vivo uterotropic bioassay using immature female mice (Isenhower et al., 
1986). However, an NIH study found that uterine, ovarian, and testicular atrophy occurred in 
rodents fed 25,000ppm APAP and ovarian cysts decreased in rodents fed 3,000-6,000 ppm 
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(NTP). Case studies conducted at Harvard Medical School found that APAP use is associated 
with a decreased risk of ovarian cancer (Cramera et al., 1998) and alters basal gonadotropin and 
estradiol levels in women who take APAP for menstrual pain (Cramerb et al., 1998). 
 
Ishikawa Cells as an in vitro estrogen-screen model 
 
Ishikawa cells are a human endometrial adenocarcinoma cell line established in 1985 
from an endometrial adenocarcinoma of a 39-year old woman in Japan. This cell line is estrogen 
receptor (ER) and progesterone receptor (PR) positive in both in vitro cell cultures and in 
induced tumors in mice (Hata et al., 1992; Nishada et al., 1985). Kassan et al. (1989) detected 
two different cytosolic estrogen receptors with Kd values of approximately 0.02 and 6nM. 
Estradiol has a variety of effects upon Ishikawa cells including: increased cell proliferation 
(Holinkaa et al., 1986); upregulation of progesterone receptors (Holinkaa et al., 1986); increased 
DNA polymerase α activity (Holinkaa et al., 1986); increased cerbB2/NEU proto-oncogene 
protein expression (Markogiamakis et al., 1997); increased intracellular β-endorphin and release 
(Makrigiannakis et al., 1992); increased alkaline phosphatase enzyme activity and mRNA 
(Albert et al., 1990; Holinkab et al., 1986). Ishikawa cells are not dependent upon estrogen for 
cell growth; however, estradiol (E2) does stimulate cell proliferation under serum-free and 
growth factor–free conditions (Holinka et al., 1989; Nishada et al., 1985). The extreme 
sensitivity of estrogen-inducible alkaline phosphatase in Ishikawa cells makes this cell line ideal 
for in vitro estrogen-screening bioassays. Studies by Littlefield et al. demonstrate an estrogen 
microtiter assay that detects alkaline phosphatase activity with maximal stimulation at 10-9M E2, 
and with detectable stimulation at concentrations as low as 10-12M E2 (Littlefield et al., 1990).  
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Antiestrogens have mixed agonist/antagonist activities in Ishikawa cells. 4-
hydroxytamoxifen (OHT) alone significantly stimulates both alkaline phosphatase activity 
(Markewicz et al., 1997) and cell proliferation (Anzai et al., 1989) at concentrations of 1-10µM, 
but when combined with estradiol OHT inhibits estradiol-induced activity and cell proliferation 
(Simard et al., 1997; Holinka et al., 1996). Although OHT’s partial agonist activities are not well 
understood, studies by Barsalou et al. (1998) indicate that it has the ability to bind both the 
estrogen-responsive-element (ERE) and AP1 DNA-binding sites in Ishikawa cells. Alkaline 
phosphatase activity induced by E2, OHT, Droloxifene or Raloxifene can be overcome by the 
complete antagonist EM-800 (Simard et al., 1997). Antiestrogen ICI 164,384 inhibits estradiol-
induced alkaline phosphatase at the mRNA level (Albert et al., 1990).  
 
Alkaline Phosphatase 
 
Alkaline phosphatase is an intrinsic membrane protein with a molecular weight of 
70,000-125,000 (Ghosh et al., 1968) that exists as a homodimer of homogeneous subunits with 
the catalytic site exposed on the extracellular side of the plasma membrane (Rustin et al., 1979). 
This enzyme cleaves phosphate groups from phosphate-esters, and, although not completely 
understood, it appears to play a role in cell homeostasis and metabolism. In humans alkaline 
phosphatase exists in 4 different isotypes: intestinal, placental, liver-bone-kidney, and germ cell 
(Frohlander et al., 1991). Clinically, serum alkaline phosphatase levels are used to screen for 
bone disease, liver dysfunction, and has been associated with the development of several human 
cancers such as lung, ovary, gastrointestinal and uterine cancer by the type of isoenzyme 
detected. 
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In Ishikawa cells alkaline phosphatase exists in 3 isoenzymes: intestinal, placental and 
liver-bone-kidney (McKenna et al., 1979; Mulivor et al., 1985). Immunological assays show that 
alkaline phosphatase is present in Ishikawa cells in the following proportions: liver-bone-kidney 
77.9%, placental 21.7% and intestinal <1% (Albert et al., 1990). In estradiol-stimulated cells the 
placental isoenzyme increases to 43.1%, liver-bone-kidney decreases to 55.1% and intestinal 
remains the same (Albert et al., 1990). 
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Hypothesis 
 
 This study tests the hypothesis that APAP will have estrogen-like activity on 
estrogen-inducible alkaline phosphatase activity in Ishikawa cells. Previous studies demonstrate 
that APAP has estrogen-like activity in breast cancer cell proliferation studies (Harnagea-
Theophilus et al., 1998) and inhibits estrogen-induced vitellogenin production in isolated trout 
liver cells (Miller et al., 1999). No appreciable interactions between APAP and the estrogen 
receptor have been found (Harnagea-Theophilusb et al., 1999, Isenhower et al., 1986) and the 
mechanism by which APAP alters these estrogenic-responses is unclear. In addition, case studies 
indicate an association between APAP and lowered risk of ovarian cancer and altered basal 
hormone levels, including estrogen, in women who take the drug (Cramera,b et al., 1998). 
Investigation of APAP's estrogen-altering effects is necessary to identify the possible impact, if 
any, that APAP may have upon estrogen-responsive processes in human health and to identify 
the mechanism behind this activity. 
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Methods 
Cell culture 
 
Ishikawa endometrial adenocarcinoma cells were a gift from the laboratory of Jacques 
Simard (CHUL Research Center, Quebec, Canada). Ishikawa cells are maintained in Minimum 
Essential Media (MEM) (Gibco) supplemented with 10% fetal bovine serum and 0.1% 
gentamycin. Cells are incubated at 37°C, 5% CO2 and passed by trypsinization when they reach 
~80% confluency. 
Studies by Holinka et al. (1989) have shown that Ishikawa cells are able to grow and 
retain their estrogen-responsiveness in serum-free medium although maximal cell density is 
lower than estrogen supplemented medium. In order to achieve low basal levels of estrogen-
inducible alkaline phosphatase activity, at least 2 weeks prior to the beginning of an experiment, 
cell medium is changed to estrogen-free EFBM consisting of 1:1 combination of phenol red-free 
Dulbecco’s Modified Eagle Medium (PRF-DMEM) (Gibco) and F:12 (Ham) Nutrient Mixture 
(Gibco), supplemented with 2% stripped fet al. bovine serum (FBS), 1% l-glutamine and 0.1% 
gentamycin. 
 FBS is stripped of steroid hormones by the following charcoal-dextran method. Twenty 
milligrams of sulfatase (Sigma) are added to 200ml fet al. bovine serum and incubated at 37°C 
for two hours. Twenty grams of activated charcoal (Sigma) are washed twice by addition of 
200ml deionized H2O followed by centrifugation at 3000 rpm for 10 minutes. Two grams of 
dextran (Sigma) are added to charcoal for 1 hour in 400ml deionized H2O at room temperature 
using a spin bar. Twenty milliliters of dextran-treated charcoal (DCC) is centrifuged and 
deionized H2O discarded. DCC is added to sulfatase-treated FBS for 30 minutes in a 56°C shaker 
waterbath, followed by centrifugation at 3000 rpm for 10 minutes. The DCC is discarded, and 
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serum is treated two more times with DCC for a total of three strippings. Final centrifugation is 
done at 9,000 rpm for 30minutes at 5°C; serum is filter-sterilized and stored at -20°C. 
 
Alkaline Phosphatase Activity Determination 
 
Alkaline phosphatase is an estrogen-inducible gene in Ishikawa Cells and has been used as a 
marker for estrogen-responsiveness in this cell line (Albert et al., 1990, Holinka et al., 1986). 
Previous studies have shown that incubating Ishikawa cells for 5 days with increasing 
concentrations of estradiol caused up to a maximal 15-fold increase in activity compared with 
non-stimulated controls (Simard et al., 1997). The alkaline phosphatase activity assay is a simple 
and inexpensive colormetric assay performed in CoStar 96-well cell culture plates as described 
by Littlefield et al (1990). Enzyme activity is determined by the rate of conversion of the 
colorless substrate para-nitrophenol phosphate (pNPhP) to yellow colored product para-
nitrophenol (pNPhOH) by cleavage of an inorganic phosphate group (Henthorn et al., 1988): 
 
 
pNPhP + H2O  →  pNPhOH + HPO4- 
 
As product is formed absorbence increases as measured by spectrophotometer at 405nm. 
Alkaline phosphatase activity is determined by calculation from the change in absorbence per 
minute to the molar concentration of para-nitrophenol produced per minute per well using the p-
nitrophenol extinction coefficient. Controls for all experiments include untreated cells to serve as 
a negative control showing basal level of activity and estradiol treatment as a positive control to 
indicate estradiol-induced alkaline phosphatase activity. 
alkaline 
phosphatase 
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Calculations: 
Xmoles of product p-nitrophenol per well = (1M p-NP/10,000 abs units) x (change in abs./min) x (5x10-5 
L) 
p-nitrophenol Extinction Coefficient: 1M p-nitrophenol Abs405 = 10,000units 
Change in absorbence per minute = AbsT1 –AbsT2 / minutesT1- T2 
 
Induction of Alkaline Phosphatase: 
 
A nearly confluent flask of Ishikawa cells in EFBM is harvested with 0.25% trypsin and 
plated in CoStar 96-well plates at 7x103 cells/ml in 100µl aliquots. Cells are allowed to adhere to 
plates for 24 hours followed by addition of test compounds in 50µl aliquots. Cells are exposed to 
test compounds for 96 hours, with one media change at 48 hours. At the end of the exposure 
period individual wells are assayed for cellular alkaline phosphatase activity and total cellular 
protein as determined by fluorescamine. Alkaline phosphatase activity was determined for n=5 
wells, and protein determination was n=3 per experiment. 
At the end of the exposure period media is removed by inversion and plates are rinsed 
twice by gentle emersion and swirling in 1 liter of phosphate-buffered saline (PBS). PBS is 
shaken out gently by inversion, and plates is blotted with paper towl. Covered plates fozen at -
80°C for at least 10 minutes then thawed at 37°C for 3 minutes to lyse cells. Fifty microliters of 
5mM para-nitrophenol phosphate solution (23.07mg p-nitrophenol phosphate/10ml diethylamine 
MgCl2) are added to each well. Formation of product, para-nitrophenol (pNP), is monitored by a 
96-well plate spectrometer (SPECTRAMAX 340PC) at 405nm from 0-60 minutes at 30°C. 
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Total Cellular Protein Determination by Fluorescamine  
 
In addition to alkaline phosphatase enzyme activity, total cellular protein was measured 
in order to determine to what extent changes in enzyme activity was reflected in protein 
concentrations. 
Fluorescamine is a reagent that reacts instantaneously with amines to produce 
fluorophors (365nm excitation, 475 emission) by the ninhydrin-phenylacetaldehyde reaction. 
Fluorescamine as well as its hydrolysis products are nonfluorescent (Udenfriend et al., 1972) 
(Fig. 4).  
Cells in 96 wells are rinsed and freeze-thawed in the same manner as described in 
Alkaline Phosphatase Activity Assay. To each well, 155µl PBS plus 45µl fluorescamine reagent 
(0.018g/30ml acetonitrile) are added. Fluorescence is allowed to stabilize for five minutes, then 
read with fluorimeter (Cytofluor 400) read at 360nm excitation, 460 emission. Bovine serum 
albumin (BSA) standards are prepared in the range of 0-80ug from a 1mg/ml BSA solution and 
fluorescence is determined for individual wells. Total cellular protein per individual well is 
extrapolated from the albumin standard curve. 
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Figure 4. Ninhydrin-phenylacetaldehyde reaction (Reprinted with permission from 
Udenfriend, S., et al.,  (1972) Fluorescamine: a reagent for assay of amino acids, 
peptides, proteins, and primary amines in the picomole range. Science. Nov 
24;178(63):871. Copyright 1972 American Association for the Advancement of Science.) 
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Lactate Dehydrogenase Cytotoxicity Assay 
 
Lactate dehydrogenase (LDH) is a cytosolic enzyme present in all mammalian cells. The 
cell membrane is impermeable to LDH under normal healthy conditions; however, damage to the 
membrane can result in changes in membrane permeability leading to LDH release into the 
extracellular fluid (Rae et al., 1986). This assay is based on the ability of LDH to catalyze the 
reaction: 
 
Lactate + NAD+ ⇔ Pyruvate + NADH 
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LDH is measured indirectly as the rate of change in absorbance at 340nm, which actually 
reflects the pyruvate-dependent decrease in concentration of NADH but is attributed to the 
activity of LDH present in the sample. NADH concentrations decrease as LDH catalyzes the 
reaction of pyruvate to lactate with conversion of one NADH to NAD+. LDH levels are 
measured in both cell supernatant and cell lysate and normalized to protein concentration per 
sample as determined by Bio-Rad Protein Assay. 
 
LDH Determination 
A confluent flask of Ishikawa cells was placed in EFBM 24 hours prior to beginning the 
experiment. The following day cells were plated at 1.3 x 106 cells/well into CoStar 6-well plates 
and allowed to adhere for 24 hours. Cells were treated with 0, 0.1mM, 0.3mM, 1.0mM, 10mM 
and 20mM APAP, and then assayed at 24 and 96 hours. At the end of the incubation period cell 
supernatant was removed for determination of LDH released by cells. Supernatant (400µl) was 
added to 510µl LDH prep buffer (0.2M potassium phosphate  pH 7.3), 30µl 10mM Na Pyruvate, 
60µl 2mM NADH (1.42mg/ml 0.1 M potassium phosphate). To disrupt cells and release 
intracellular LDH, 1ml 0.1% Triton X-100 was added to each well, cells were scraped off the 
well by cell scraper and pipetted several times to completely disrupt cell membranes, creating a 
cell lysate. To determine intracellular LDH activity 20µl of cell lysate were added to 890µl LDH 
prep buffer (0.2M potassium phosphate pH 7.3), 30µl 10mM Na Pyruvate, 60µl 2mM NADH 
(1.42mg/ml 0.1 M potassium phosphate). Absorbence was read at 5-second intervals for 60 
seconds by continuous read with the spectrophotometer (Bausch and Lomb Spectronic 1001). 
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Protein Concentration Determination 
Bio-Rad Protein Assay is based upon the Bradford method, where an acidic dye binds 
protein in solution (Bradford 1976). The Bio-Rad reagent dye changes color in response to 
various concentrations of protein and binds primarily basic and aromatic amino acid residues, 
especially arginine (Compton1985). The absorbance maximum for this protein bound dye occurs 
at 595nm and is read with a spectrometer. Sample protein concentration is extrapolated by 
comparison to a BSA standard curve. The microassay procedure was modified from the 
manufacturer's protocol. For the protein standard curve, BSA was prepared at 2mg/ml and 8 
dilutions were made in the range of 25µg-2,000µg protein. Cell lysate samples were diluted 1:10 
in deionized H2O. In a CoStar 96-well plate 160µl of diluted sample or standard plus 40µl of 
concentrated Bio-Rad reagent were added to wells in triplicate. Plates were incubated for 5 
minutes at room temperature, and then absorbance was measured at 595nm with a spectrometer. 
Protein concentration per 160 µl was extrapolated from absorbence value using the BSA 
standard curve; protein per well was calculated with the following equation: 
 
Example Calculation:  
X µg protein/well = (µg protein extrapolated from standard curve)x(1000µl total sample volume/160µl) 
x(10 dilution factor) 
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Effect of Acetaminophen (APAP) on Alkaline Phosphatase Enzyme Activity 
 
The purpose of this assay was to determine if APAP interacts directly with alkaline 
phosphatase enzyme, altering its activity. Ishikawa cells were trypsinized, diluted to 
2.6x105cells/ml and 8ml of suspension were added to six 100mm petri dishes. Cells were 
incubated for 24 hours at 37°C, 5% CO2. Three plates were treated with 2ml of estradiol solution 
(3µl 10mM E2 in 6ml EFBM) for a final concentration of 1nM estradiol to induce alkaline 
phosphatase activity. Three control plates were dosed with 2ml of EFBM containing vehicle (3µl 
EtOH in 6ml EFBM) and incubated for 72 hours. Medium was removed and plates rinsed twice 
with PBS. Cells were removed using 0.5ml PBS and a cell scraper, then pipetted into 15ml tubes 
on ice to achieve a final volume of 1.5ml suspended cells. Cells were lysed by sonication and 
used for enzyme activity assay and Bio-Rad protein assay.  
A concentration-response curve determined that 5µl of cell lysate produced alkaline 
phosphatase activity within a linear range. In a 96-well plate, 5µl cell lysate, 25µl of APAP 
solution and 50µl of substrate (para-nitrophenol phosphate) were added to wells in triplicate. 
Estradiol-induced cell lysate was exposed to 2.5, 1.0, 0.5 or 0.25mM APAP. Alkaline 
phosphatase activity was measured as change in absorbance at 405nm as previously described. 
 
Fluorescence Microscopy: Calcein Staining 
 
The purpose of this experiment was to examine live Ishikawa cells for visible 
morphological changes after treatment with estradiol and APAP combination. The LIVE/DEAD 
Viability/Cytotoxicity Assay Kit (Molecular Probes) contains a cell-permeant non-fluorescent 
calcein AM which is enzymatically converted by intracellular esterases to an impermeable 
intense green-fluorescence calcein at 495nm excitation, 515nm emission. While live cells have 
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this endogenous esterase activity, dead cells do not. Nonviable cells may have esterase activity 
present; however, due to compromised cellular membranes they are unable to retain the 
converted fluorescent product. The method used was adopted from the Fluorescent Microscopy 
Protocol provided by the manufacturer. Ishikawa cells in EFBM were plated in CoStar 24-well 
plates at 3x104 cells/ml in 1ml aliquots and allowed to adhere to the plates for 24 hours. Cells 
were treated the next day with 1nM estradiol plus 0, 0.03, 0.1, 0.3, or 1mM APAP and incubated 
for 72 hours. Control cells were treated with media only. EthD-1 solution (4uM) was prepared 
from the 2mM EthD-1 stock solution (20µl EthD-1, 10ml PBS). Media was removed from cells 
and one ml of dye solution added. Cells were incubated at room temperature for 30 minutes. 
Cells were viewed and photographed by fluorescent microscopy using a fluorescent filter at 
485nm excitation, 530nm emission at 80X magnification.  
 
Statistics 
 
Statistical analysis of alkaline phosphatase activity, protein concentration and LDH 
experiments were done by One-Way or Two-Way ANOVA followed by the Tukey’s Test when 
significant differences (p<0.5) between group means were detected.  
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Results 
Estradiol Induction of Alkaline Phosphatase in Ishikawa Cells 
 
Previous studies have demonstrated that Ishikawa cells have estrogen-responsive alkaline 
phosphatase activity that responds maximally at 10-8M E2, with the highest activity reached 96 
hours after E2 addition (Holinka et al., 1986). To ensure that this system was working 
appropriately in our hands, an E2-concentration-response curve for alkaline phosphatase activity 
in Ishikawa cells was performed. Cells were treated with 0.003-81nM estradiol as described in 
methods; control cells were treated with media only. Results (Fig.5) show that alkaline 
phosphatase activity was induced in a concentration-dependent manner with concentrations of 
0.01-81nM E2 producing activity significantly higher than control. Maximal induction of alkaline 
phosphatase activity, ~5-fold higher than control, was achieved at 0.3, 1 and 3nM E2, followed 
by an apparent decline at 9, 27 and 81nM E2. 
The amount of total cellular protein in cultures was also determined as described in 
methods. Results shown in Fig.6 indicate that estradiol increased protein ~1.5-fold above control 
at 0.003, 0.01, 0.03, 0.1, 0.3, and 3nM E2 while 1, 9, 27 and 81nM E2 did not significantly alter 
protein levels. Although cell protein did increase at some concentrations of E2, this did not occur 
in a concentration-dependent manner nor was it near the magnitude of increase in the alkaline 
phosphatase activity measured at corresponding E2 concentrations. These experiments 
demonstrate that estradiol induced alkaline phosphatase activity in Ishikawa cells and that this 
increase in activity was only partly attributed to an increase in total cellular protein. 
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Acetaminophen Inhibits Basal Alkaline Phosphatase activity in Ishikawa Cells 
 
Previous studies in our laboratory have shown that APAP induced cell proliferation in 
ER+ MCF-7 breast cancer cells and that antiestrogens inhibit APAP-induced proliferation 
(Harnagea-Theophilus et al., 1998). It was hypothesized that APAP would have a similar 
stimulatory effect on estrogen-inducible alkaline phosphatase activity in Ishikawa cells. Cells 
were treated as described with 0.03, 0.1, 0.3, or 1mM APAP; control cells were treated with 
media alone. The concentrations of APAP chosen corresponded with the previous studies 
conducted with MCF-7 cells (Harnagea-Theophilus et al., 1998). Results in Fig.7 show that 
APAP did not induce alkaline phosphatase, rather, APAP significantly inhibited basal levels of 
alkaline phosphatase activity ~50% compared to control cells. Levels of alkaline phosphatase 
activity among APAP treated groups were not significantly different from one another. This 
experiment was repeated 3 more times for a total of 4 experiments, all with the same results. In 
two of four experiments, 0.3 and 1mM APAP treatment decreased total cellular protein 20% and 
60% respectively, relative to control cells (Fig. 8). In the other two experiments, total cellular 
protein was not significantly altered by APAP (not shown).  
Results from this experiment do not support the initial hypothesis that APAP would 
increase estrogen-inducible alkaline phosphatase in Ishikawa cells. Acetaminophen decreases 
basal levels of alkaline phosphatase activity and this effect may be in part due to decreases in 
total cellular protein at 0.3 and 1mM APAP concentrations.  
 
Acetaminophen Inhibits Estradiol-Induced Alkaline Phosphatase 
 
The purpose of the next experiment was to determine if APAP would have the same 
inhibitory affect upon estradiol-induced alkaline phosphatase activity as it did on the basal 
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enzyme activity. Cells were treated with 1nM E2 plus 0.03, 0.1, 0.3, or 1mM APAP; control cells 
were treated with media only. The concentration of 1nM E2 was chosen because it induced a 
strong yet submaximal alkaline phosphatase activity (Fig. 5). Results (Fig.9) show that 1nM E2 
induced alkaline phosphatase activity ~9-fold above control level and that 0.1, 0.3, 1mM APAP 
inhibited this activity by 29%, 62% and 91%, respectively. The effects of E2 and APAP on total 
protein levels (Fig.10) show that estradiol (1nM) alone had no significant effect on protein 
concentration, while the combination of 1nM E2 plus 0.3 or 1mM APAP significantly decreased 
protein concentration compared to both control and 1nM E2; protein concentrations decreased 35 
and 70%, respectively, compared to 1nM E2. These data are representative of 4 experiments. 
These experiments indicate that APAP inhibits estradiol-induced alkaline phosphatase 
activity in a concentration-dependent manner at 0.1, 0.3 and 1mM concentrations. 
Acetaminophen also decreases estradiol-induced protein concentrations at 0.3 and 1mM 
significantly lower than both control and estradiol-treated cells, suggesting that it may be toxic at 
these levels. 
 
Lactate Dehydrogenase Cytotoxicity Assay 
 
In order to determine if cytotoxicity was playing a role in APAP’s inhibitory effect on 
E2-induced alkaline phosphatase activity, a lactate dehydrogenase (LDH) release assay was 
conducted, which is a well-characterized marker of cell cytotoxicity (Ray et al., 2000). Ishikawa 
cells were plated and treated with 0.1, 0.3, 1, 10 or 20mM APAP; control cells were treated with 
media alone. High APAP concentrations (10 and 20mM) were used in this study as positive 
controls for toxicity. Intracellular LDH activity obtained from cell lysate and LDH activity 
released into medium were determined after 24 and 96-hours of exposure as shown in Table 1; 
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intracellular and released LDH activity were normalized to total cellular protein as obtained from 
cell lysate. Total LDH activity was the sum of intracellular and released LDH activity. 
Percentage released from total LDH expresses the amount of LDH activity released into the 
media as a percentage of the total LDH per well.  
After 24-hours cells treated with 0.3, 1, 10 and 20mM APAP showed a decline in 
intracellular LDH activity. Released LDH activity increased slightly when cells were exposed to 
1 and 20mM APAP; 10mM APAP-treated cells released LDH almost 4-times higher than control 
but this effect was not reproducible. This indicates that after 24-hours there is little toxicity in 
Ishikawa cells exposed to APAP at the concentrations tested. By 96-hours LDH release increased 
dramatically in cells treated with 1, 10 and 20mM APAP compared to control; LDH release 
increased to a lesser degree in 0.3mM APAP-treated cells. Intracellular LDH remained lower in 
0.3, 1, 10 and 20mM APAP-treated cells compared to control. In summary, after 96-hours of 
exposure Ishikawa cells may show signs of toxicity with 0.3mM APAP treatment, and at 1, 10 
and 20mM APAP toxicity is apparent. 
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Table 1. Effect of APAP on LDH Release from Ishikawa Cells 
Control 0.1mM 0.3mM 1mM 10mM 20mM 
24-hours 
 Total LDH* 1.49 1.43 1.16 1.09 1.03 1.22 
 Intracellular* 1.46 1.41 1.14 1.06 0.95 1.18 
 Released* 0.03 0.02 0.02 0.03 0.08 0.04 
 % released of total 2% 1.4% 1.7% 2.8% 7.8% 3.3% 
  LDH 
96-hours 
 Total LDH* 2.05 2.33 1.90 1.16 1.09 0.84 
 Intracellular* 1.97 2.24 1.76 0.91 0.89 0.47 
 Released* 0.08 0.09 0.14 0.25 0.20 0.37 
 % released of total 3.9% 3.9% 7.4% 21.6% 18.4% 44.1% 
 LDH 
 
 
 
Table 1. Cells were treated with 0.1, 0.3, 1, 10 or 20mM APAP and assayed for LDH 
activity at 24 and 96-hours. Following exposure period, media removed from cells was assayed 
for released LDH activity and cell lysate was prepared and assayed for intracellular LDH activity 
and total cellular protein. Intracellular represents total cellular LDH activity (*∆Abs340nm/min/mg 
total cellular protein); released LDH represents total LDH activity released into medium 
(*∆Abs340nm/min/mg total cellular protein); total LDH is the sum of intracellular and released 
LDH. Percentage of total LDH released expresses the amount of LDH activity released into the 
media as a percentage of the total LDH per well. While treatment with APAP for 24-hours did 
not affect LDH release, after 96-hours there was an increase in %LDH release in 0.3, 1, 10 and 
20mM APAP-treated cells indicating cytotoxicity. 
 
Alkaline Phosphatase Enzyme Is Not Directly Inhibited By Acetaminophen  
 
The next experiment was designed to determine if APAP directly inhibits alkaline 
phosphatase enzyme activity. Cells were plated, treated with estradiol to induce alkaline 
phosphatase and a cell lysate containing alkaline phosphatase was prepared as described in 
methods. Alkaline phosphatase assays were conducted in the absence (control) or presence of 
0.25. 0.5, 1.0 or 2.5mM APAP. Alkaline phosphatase specific activity (abs405nm/min/µg prot) was 
determined and is presented in Table 1. Results from this experiment indicate that none of the 
APAP concentrations tested directly inhibit the enzymatic activity of alkaline phosphatase. 
Experiment was done in duplicate with analogous results. 
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Table 2. Effect of APAP on Alkaline Phosphatase Enzyme Activity 
 Control 0.25mM APAP 0.5mM APAP 1.0mM APAP 2.5mM APAP 
0.81 0.85 0.85 0.98 0.89 
 
Table 2. Ishikawa cell lysate containing estradiol-induced alkaline phosphatase was 
treated with 0.25, 0.5, 1.0 or 2.5mM APAP and assayed for enzyme activity. Specific 
activity*(∆Abs340nm/min/mg total cellular protein) of estradiol-induced alkaline 
phosphatase enzyme was not altered by addition of APAP. 
 
Effects of Varying Concentrations of E2 and APAP on Alkaline Phosphatase Activity and 
Protein Concentration 
 
The next set of experiments was designed to determine if the degree of APAP inhibition 
of alkaline phosphatase activity was affected by the concentration of E2 (Table 3). Cells were 
treated with either 0.01, 0.1 or 1nM E2 in combination with 0, 0.03, 0.1, 0.3, or 1mM APAP; 
control cells were treated with media only. At 1mM APAP, E2-induced alkaline phosphatase 
activity decreased approximately 77% at all E2-concentrations examined. Inhibition of estradiol-
induced alkaline phosphatase activity at 0.3mM APAP ranged from 16% to 34% and was not 
dependent on the concentration of E2. At 0.1 and 0.03mM APAP, estradiol-induced alkaline 
phosphatase activity was not significantly inhibited. Furthermore, alkaline phosphatase activity 
was significantly increased in Ishikawa cells treated with 0.01nM E2 plus 0.03mM APAP. 
Results shown in Table 3 indicate that APAP inhibition of estradiol-induced alkaline 
phosphatase activity does not change significantly with increasing concentrations of estradiol. 
Protein concentrations were decreased at all estradiol concentrations with 1mM APAP, and less 
dramatically at 0.3mM APAP. Treatment with 0.1 or 0.03mM APAP had little, if any, effect on 
protein concentrations at 0.01 and 1nM E2; 0.01nM E2 showed slightly lower protein 
concentrations for all APAP treatments, compared to the other two estradiol-treatment groups.  
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There is some similarity between trends in decreased estradiol-induced alkaline 
phosphatase activity and protein concentrations in response to different concentrations of APAP. 
However, the magnitude of inhibition of estradiol-induced alkaline phosphatase activity is not 
equivalent to the decrease in protein for the majority of treatment groups. APAP (1mM ) 
substantially decreased E2-induced alkaline phosphatase activity relative to protein 
concentrations. Increased estradiol-induced alkaline phosphatase activity at 0.03 and 0.1mM 
APAP does not correlate to protein data, as protein concentrations decrease slightly or do not 
change compared to controls. Cells treated with 0.3mM APAP plus 0.01, 0 .1 or 1nM E2 showed 
some similarity between alkaline phosphatase activity and protein levels. These results indicate 
that APAP does affect cellular protein concentrations of estradiol-treated Ishikawa cells; 
however, this is not always equal to the magnitude of the effect APAP appears to have on 
estradiol-induced alkaline phosphatase activity. Therefore, it appears that APAP reduces 
estradiol-induced alkaline phosphatase activity more than it reduces cellular protein, and this 
effect does not change with increasing concentrations of E2. 
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Table 3. Changes in alkaline phosphatase activity and protein concentration with 
varying combinations of E2 and APAP 
 
E2-induced Alkaline Phosphatase Activity % of E2 control 
 0.03mM APAP 0.1mM APAP 0.3mM APAP 1mM APAP 
0.01nM E2 137 + 18.6 115 + 9.5 70.5 + 3.3 22.5 + 3.7 
0.1nM E2 91.3 + 12.1 109.8 + 10.8 83.5 + 7.0 23.3 + 3.6 
1nM E2 106.8 + 4.2 90.8 + 6.9 65.5 + 9.5 23.5 + 6.4 
     
Total Protein % of E2 control    
 0.03mM APAP 0.1mM APAP 0.3mM APAP 1mM APAP 
0.01nM E2 92.0 + 6.7 99.6 + 6.7 76.8 + 8.5 79.2 + 13.4 
0.1nM E2 87.8 + 8.6 79.3 + 5.5 68.8 + 18.4 43.3 + 15.8 
1nM E2 90.8 + 15.1 92.8 + 8.2 83.3 + 8.7 59.3 + 28.6 
 
Cells were plated in 96-well plates and exposed to varying concentrations of E2 and APAP. After 96-
hours incubation with test compounds, individual wells were assayed for alkaline phosphatase activity 
or protein concentration by fluorescamine. Results shown are the mean of 4 experiments, with 
individual treatment group data expressed as percent of activity or protein concentration compared to 
the corresponding estradiol-only treatment group (100%) from that experiment. Control cells treated 
with media were used to indicate induction of alkaline phosphatase activity by E2 (not shown). Results 
show that increasing concentrations of E2 did not significantly alter the effect of APAP on alkaline 
phosphatase or protein concentrations at the various concentrations tested. Standard error is shown. 
 
APAP Amplifies Antiestrogen Effects in Ishikawa Cells  
 
The next study tested the hypothesis that APAP would enhance the inhibitory effect of 
antiestrogens on E2-induced alkaline phosphatase. Previous studies demonstrated antiestrogens 
inhibit E2-induced alkaline phosphatase activity in Ishikawa cells (Holinka et al.,1986; Simard et 
al.,1997; Littlefield et al.,1990). Cells were treated with 0.1nM E2 in combination with 0.01, 0.1, 
1 or 10µM 4-hydroxy tamoxifen (OHT) (Sigma) or ICI 182,780 (Zeneca Pharmaceuticals); 
control cells were treated with media only. Concentrations of anti-estrogens were chosen based 
upon current literature (Holinka et al.,1986; Simard et al.,1997; Littlefield et al.,1990). The 
concentration of 0.1nM E2 was chosen because it induced submaximal alkaline-phosphatase 
activity within the linear range. Results shown are representative of experiments done in 
triplicate. Treatment with 0.01, 0.1, or 1µM OHT inhibited E2-induced alkaline phosphatase 
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activity ~45% from 1nM E2-treated cells (Fig.11), with no significant differences between 
alkaline phosphatase activity of the different OHT treatment groups, while 10µM OHT 
eliminated E2-induced alkaline phosphatase activity completely. Fig.12 shows that OHT had no 
significant effect on cellular protein concentrations except at 10µM where protein declined to 
almost zero, indicating a toxic effect., In one of the two experiments 0.01µM OHT decreased 
protein 32% compared to 1nM E2, but this data was inconsistent with the other data.  
Results in Fig.13 show that ICI 182,780 inhibits E2-induced alkaline phosphatase activity 
95% relative to cells treated with 1nM E2 alone. Fig.14 shows an ICI 182,780 concentration-
dependent decrease in cellular protein, with 0.1, 1 and 10µM ICI resulting in 27%, 36% and 61% 
decrease, respectively. Results for both antiestrogens shown are representative of two separate 
experiments with similar results. 
The next part of this experiment was to examine the effect of APAP in combination with 
OHT, on E2-induced alkaline phosphatase. Cells were plated and treated as described in methods 
with either 0.1nM E2, 0.1nM E2 + 0.01µM OHT, or 0.1nM E2 + 0.01µM OHT + 0.03, 0.1, 0.3 or 
1mM APAP. The concentration 0.01µM OHT was chosen because it was the lowest 
concentration that produced significant inhibition of 0.1nM E2-induced alkaline phosphatase 
activity. Results (Fig.15) show that 0.1nM E2 induced alkaline phosphatase activity ~7.5-fold, 
and this was decreased ~65% by 0.01µM OHT. Addition of 0.1, 0.3 and 1mM APAP enhanced 
this inhibition of activity by an additional 38%, 71% and 90% compared to OHT alone. Protein 
concentrations (Fig.16) were doubled by 0.1nM E2 compared to control and were unaffected by 
addition of 0.01µM OHT alone. Addition of 0.3 and 1mM APAP decreased protein 
concentrations 36% and 73% compared to E2 plus OHT alone, while lower concentrations 
produced no significant effect. Again, although APAP produced a significant decrease in cellular 
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protein concentrations in some treatment groups, the effectsproduced do not account for the total 
reduction of enzyme activity. 
 
Fluorescent Microscopy 
 
Calcein fluorescent staining was utilized to show morphological changes in live Ishikawa cells in 
response to E2 and APAP treatments (Fig.17). Cell permeant non-fluorescent calcein is 
enzymatically converted to an impermeable green-fluorescent product by esterases and retained 
in the cell. Results show that Ishikawa cells in the control group grow in large clusters adhered to 
the plate with individual cells well defined. 1nM E2-treated cells appear similar to those of 
control. Cells treated with 1nM E2 + 0.03mM APAP do not appear drastically altered, but 
clusters of cells are smaller. Cells treated with 1nM E2 + 0.1mM, or 0.3mM APAP appear more 
misshapen and there are less cells in the particular fields photographed. Ishikawa cells treated 
with 1nM E2 + 1mM APAP were distorted and most cells no longer adhered to the plate, 
indicating toxicity. 
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Fig.5. Estradiol induces alkaline phosphatase activity in Ishikawa cells. Cells were plated in 
96-well plates and exposed to 0.003-81nM E2 for 96-hours, then assayed for alkaline 
phosphatase activity. Alkaline phosphatase was induced in a concentration-dependent manner 
with maximal activity at 1nM E2, approximately 5-fold higher than control levels. Each point 
represents the mean + standard error of five individual wells from a single experiment; a total of 
four experiments were conducted with similar results. *Activity increased significantly 
compared to control (p<0.05). 
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 Fig.6. Estradiol increases total cellular protein concentrations in Ishikawa cells. Cells were 
plated in 96-well plates and exposed to 0.003-81nM E2 for 96-hours, then assayed for total 
cellular protein by fluorescamine assay. Protein concentrations increased 1.5-fold with 0.003-
0.3nM E2-treatment, but not in a concentration-dependent manner. Each point represents the 
mean + standard error of four individual wells from a single experiment; a total of four 
experiments were conducted with similar results. *Protein concentration increased significantly 
compared to control (p<0.05). 
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 Fig.7. Acetaminophen (APAP) inhibits basal alkaline phosphatase activity in Ishikawa 
cells. Cells were plated in 96-well plates and exposed 0.03, 0.1, 0.3, and 1mM APAP for 96-
hours, then assayed for alkaline phosphatase activity. Alkaline phosphatase was significantly 
inhibited by APAP treatment at all concentrations tested compared to control cells. Each point 
represents the mean + standard error of five individual wells from a single experiment; a total of 
four experiments were conducted with similar results. *Activity decreased significantly 
compared to control (p<0.05). 
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 Fig.8. Acetaminophen (APAP) decreases total cellular protein in Ishikawa cells. Cells were 
plated in 96-well plates and exposed 0.03, 0.1, 0.3, and 1mM APAP for 96-hours, then assayed 
for total cellular protein by fluorescamine assay. Protein concentrations were unaffected by 
treatment with 0.03 and 0.1mM APAP, but were significantly decreased by 0.3 and 1mM APAP 
compared to control. Each point represents the mean + standard error of four individual wells 
from a single experiment; a total of four experiments were conducted with similar results. 
*Protein concentration decreased significantly compared to control (p<0.05). 
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 Fig.9. Acetaminophen (APAP) inhibits E2-induced alkaline phosphatase activity in 
Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of 
1nM E2 and 0.03, 0.1, 0.3, 1mM APAP for 96-hours, then assayed for alkaline phosphatase 
activity. Alkaline phosphatase was induced by 1nM E2; combinations of 1nM E2 and 0.1, 0.3, 
and 1mM APAP had significantly decreased alkaline phosphatase activity compared to 1nM E2 
alone. This inhibition of activity increased with increasing concentrations of APAP. Cells treated 
with 1nM E2+1mM APAP had alkaline phosphatase activity decreased below control levels. 
Each point represents the mean + standard error of five individual wells from a single 
experiment; a total of four experiments were conducted with similar results. *Activity increased 
significantly compared to control (p<0.05). #Activity decreased significantly compared to 1nM 
E2 (p<0.05). 
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Fig.10. Acetaminophen (APAP) decreases total cellular protein concentrations in E2-
treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a 
combination of 1nM E2 and 0.03, 0.1, 0.3, 1mM APAP for 96-hours, then assayed for total 
cellular protein by fluorescamine assay. While 1nM E2 alone had no effect on protein 
concentration, combination of 1nM E2 and 0.3,  or 1mM APAP significantly decreased total 
cellular protein in comparison to control. Each point represents the mean + standard error of four 
individual wells from a single experiment; a total of four experiments were conducted with 
similar results. *Protein concentration decreased significantly compared to control (p<0.05). # 
Protein concentration decreased significantly compared to 1nM E2 (p<0.05). 
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Fig.11. Tamoxifen inhibits E2-induced alkaline phosphatase activity in Ishikawa cells. Cells 
were plated in 96-well plates and exposed to 1nM E2, or a combination of 1nM E2 and 0.01, 0.1, 
1, 10µM OHT for 96-hours, then assayed for alkaline phosphatase activity. OHT significantly 
decreased alkaline phosphatase activity by ~50% in cells treated with 1nM E2 and 0.01, 0.1 µM 
OHT; there was no detectable activity in cells treated with 1nM E2 plus 10µM OHT. Each point 
represents the mean + standard error of five individual wells from a single experiment; a total of 
four experiments were conducted with similar results. *Activity significantly different from 
control (p<0.05). #Activity decreased significantly compared to 1nM E2 (p<0.05). 
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 Fig.12. Tamoxifen decreases total cellular protein concentrations in E2-treated Ishikawa 
cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of 1nM E2 
0.01, 0.1, 1, 10µM OHT for 96-hours, then assayed for total cellular protein by fluorescamine 
assay. Treatment with 1nM E2 or combination of 1nM E2 0.01, 0.1, 1µM OHT had no effect on 
cellular protein concentrations compared to control, however, 1nM E2 plus 10µM OHT 
decreased protein levels to almost zero indicating toxicity. Each point represents the mean + 
standard error of four individual wells from a single experiment; a total of four experiments were 
conducted with similar results. *Protein concentration decreased significantly compared to 
control (p<0.05). # Protein concentration decreased significantly compared to 1nM E2 (p<0.05). 
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Fig.13. Anti-estrogen ICI 182,780 inhibits E2-induced alkaline phosphatase activity in 
Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a combination of 
1nM E2 and 0.01, 0.1, 1, 10µM ICI 182,780 for 96-hours, then assayed for alkaline phosphatase 
activity. Estradiol-induced alkaline phosphatase activity decreased significantly and below 
control levels in cells treated with combinations of 1nM E2 and ICI 182,780; there was no 
significant difference in the activity between anti-estrogen treatment groups. Each point 
represents the mean + standard error of five individual wells from a single experiment; a total of 
four experiments were conducted with similar results. *Activity significantly different from 
control (p<0.05). #Activity decreased significantly compared to 1nM E2 (p<0.05). 
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 Fig.14. Anti-estrogen ICI 182,780 decreases total cellular protein concentrations in E2-
treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, or a 
combination of 1nM E2 and 0.01, 0.1, 1, or 10µM ICI 182,780 for 96-hours, then assayed for 
total cellular protein by fluorescamine assay. Treatment with 1nM E2 had no effect on cellular 
protein concentrations compared to control, however, 1nM E2 plus 0.01, 0.1, 1, 10µM ICI 
182,780 significantly decreased protein in a concentration-dependent manner with increasing 
concentration of ICI 182,780. *Protein concentration decreased significantly compared to control 
(p<0.05). # Protein concentration decreased significantly compared to 1nM E2 (p<0.05). 
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Fig.15. Acetaminophen (APAP) amplifies tamoxifen inhibition of E2-induced alkaline 
phosphatase activity in Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM 
E2, 1nM E2 plus 0.01µM OHT, or combination of 1nM E2 and 0.01µM OHT and 0.03, 0.1, 0.3 or 
1mM APAP for 96-hours, then assayed for alkaline phosphatase activity. Treatment with 1nM E2 
plus 0.01µM OHT inhibited E2-induced alkaline phosphatase activity and this inhibition 
significantly increased with the addition of 0.1, 0.3 and 1mM APAP compared to 1nM E2 plus 
0.01µM OHT alone. *Activity significantly different from control (p<0.05). #Activity decreased 
significantly compared to 1nM E2 (p<0.05). +Activity decreased significantly compared to 1nM 
E2 + 0.01µM OHT (p<0.05). 
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Fig.16. Acetaminophen (APAP) decreases total cellular protein concentrations in E2-OHT 
treated Ishikawa cells. Cells were plated in 96-well plates and exposed to 1nM E2, 1nM E2 plus 
0.01µM OHT, or combination of 1nM E2 and 0.01µM OHT and 0.03, 0.1, 0.3 or 1mM APAP for 
96-hours, then assayed for total cellular protein by fluorescamine assay. Treatment with 1nM E2 
increased total cellular protein significantly compared to control; treatment with 1nM E2 plus 
0.01µM OHT increased total cellular proteins compared to control but was not significantly 
different than E2-treated cells. Treatment with E2 plus OHT and 0.3 or 1mM APAP decreased 
protein concentrations significantly below E2 plus OHT-treated cells. Each point represents the 
mean + standard error of four individual wells from a single experiment; a total of four 
experiments were conducted with similar results. *Protein concentration significantly different 
from control (p<0.05). # Protein concentration decreased significantly compared to 1nM E2 
(p<0.05). + Protein concentration decreased significantly compared to 1nM E2 + 0.01µM OHT 
(p<0.05). 
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Fig.17. Calcein staining of Ishikawa shows morphological changes in response 
Acetaminophen (APAP) treatment. Cells were plated in 24-well plates and exposed to E2, and 
E2 plus 0.03, 0.1, 0.3 1mM APAP for 96-hours. Calcein (M) was added to each well and cells 
were examined using fluorescent microscopy with 80X magnification. Treatment with E2 had no 
visible effect; treatment with E2 plus 0.03, 0.1mM APAP decreased size of clusters of cells; cells 
treated with E2 plus 0.3mM APAP appear misshapen; cells treated E2 plus 1mM APAP are no 
longer attached to plate indicating toxicity. 
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Discussion 
Acetaminophen (APAP) is currently being investigated as a possible endocrine disruptor 
due to its ability to alter estrogenic responses in vitro. At therapeutic concentrations, APAP 
induced cell proliferation in ER+/PR+ MCF-7 and T47D breast cancer cells and this effect was 
successfully inhibited by addition of antiestrogens; there was no induction of cell proliferation in 
ER-/PR- breast cancer cells (Harnagea-Theophilus et al., 1998). Another study demonstrated 
APAP inhiibted estrogen-dependent vitellogenin production in trout liver cells in vitro (Miller et 
al., 1999). However, most significant to human health issues are the case studies suggesting that 
APAP use is associated with decreased ovarian cancer incidence and alteration in hormone 
levels, including estrogen, in women who take the drug (Cramera,b et al., 1998).  
The initial hypothesis was that APAP would induce estrogen-responsive alkaline 
phosphatase activity in Ishikawa endometrial cells based upon studies that indicate APAP has 
estrogen-like activity on cell proliferation in ER+/PR+ breast cancer cells (Harnagea-Theophilus 
et al., 1998). In order to test this hypothesis, Ishikawa cells were cultured in 96-well plates and 
exposed to 0.03, 0.1, 0.3 or 1mM APAP for 96-hours based upon the microtiter assay described 
by Littlefield et al. (1990). Acetaminophen concentrations were based upon those used in MCF-7 
proliferation studies by Harnagea-Theophilus et al. (1998). Alkaline phosphatase activity and 
total cellular protein concentration were determined for APAP-treated cultures and controls. 
Total cellular protein was determined in addition to enzyme activity in order to have a variable 
comparable to enzyme activity; significant changes in protein concentration could be interrelated 
to increases in enzyme activity. 
Acetaminophen decreased estrogen-responsive alkaline phosphatase activity in Ishikawa 
endometrial carcinoma cells, and thus the initial hypothesis was not borne out. Acetaminophen 
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(0.1, 0.3 and 1mM) significantly inhibited basal and 1nM E2-induced alkaline phosphatase 
activity; however, cellular protein concentrations were only inhibited by 0.3 and 1mM APAP 
alone or in combination with 1nM E2. While the degree of enzyme inhibition was larger than the 
degree of protein decrease, these effects could have been the result of APAP toxicity. LDH 
release cytotoxicity assay was conducted to ensure that the decrease in alkaline phosphatase 
activity was not due to APAP toxicity. Ishikawa cells were exposed to 0.1, 0.3, 1, 10 or 20mM 
APAP for 24 and 96 hours and then assayed for LDH release. While toxicity was not detected at 
24-hours, after 96-hours Ishikawa cells exposed to 1, 10 and 20mM APAP did release a 
considerable percentage of LDH thus indicating cytotoxicity.  
Fluorescent microscopy results (Fig. 17) support the conclusion that 1mM APAP is toxic 
to Ishikawa cells; cells are visibly misshapen and unattached to the plate. This suggests that 
inhibition of alkaline phosphatase by 1mM APAP, with or without 1nM E2, is likely due to 
APAP-toxicity. Cells exposed to 0.3mM APAP also had an increase in LDH release, but to a 
lesser degree than 1mM-treated cells while 0.1mM APAP had no effect on LDH release. 
Treatment with 0.3mM APAP significantly inhibited alkaline phosphatase activity and 
significantly decreased protein concentrations, observations that may be due to toxicity. Alkaline 
phosphatase inhibition by 0.1mM APAP was not accompanied by any effect on protein and 
cannot be correlated to any toxic effect of APAP. Therefore, the inhibitory effect of APAP on 
alkaline phosphatase activity may be due partially to toxicity at 0.3, and 1mM APAP 
concentrations; however, there is still a level of inhibition that exists in cells treated with 0.1mM 
APAP that remains unexplained.  
The next question to be addressed was a determination of any direct inhibition  of 
alkaline phosphatase enzyme activity by APAP. Results of the alkaline phosphatase enzyme 
 57 
specific activity assay (Table 1) indicate that at the concentrations tested, APAP had no effect on 
enzyme activity compared to control. In conclusion, APAP inhibits basal and E2-induced alkaline 
phosphatase activity and this is not due to direct enzyme inhibition.  
The second hypothesis determined if increasing concentrations of E2 would decrease 
APAP inhibition of alkaline phosphatase activity. Cells were treated with 0.03, 0.1, 0.3 or 1mM 
APAP plus either 0.01, 0.1 or 1nM E2; samples were then assayed for alkaline phosphatase 
activity and cellular protein. Results (Table 2) show that APAP inhibition was not affected by 
different concentrations E2. The level of inhibition by a single concentration of APAP was not 
significantly changed when estradiol was increased 10 or even 100-fold; protein concentrations 
were unaffected under the same conditions. There were no signs of competitive inhibition by 
APAP on E2-induced alkaline phosphatase activity. The results from this inhibition study are in 
agreement with studies that indicate APAP does not compete with E2 for binding at ER (Miller et 
al., 1999; Isenhower et al., 1986; Harnagea-Theophilusa et al., 1999). 
Interestingly, cells treated with 0.01nM E2 plus 0.03 or 0.1nM APAP had a stimulatory 
effect and significantly increased alkaline phosphatase activity compared to 0.01nM E2 alone. 
This effect was seen in 3 of the four experiments conducted and there were no changes cellular 
protein, suggesting that APAP may have some partial-agonist activity when combined with 
0.01mM E2.  
In the E2-APAP inhibition study (Table 3) it appears that APAP had less of an inhibitory 
effect upon 1nM E2-induced alkaline phosphatase activity than indicated in initial studies (Fig. 
7). This is a result of expressing the data as a mean of four experiments rather than showing a 
single representative experiment. There was some variation in the magnitude of response in both 
alkaline phosphatase and protein concentration within the four experiments conducted. 
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Variability resulted from Ishikawa cells being cultured in estradiol-free medium for a minimum 
of two weeks prior to an experiment in order to achieve low basal levels of alkaline phosphatase 
activity. Cells were viable for a period of approximately six-weeks under estrogen-free 
conditions, and had the highest levels of enzyme activity and protein concentration after the 
initial two-week staging period. Maximal activity and protein concentration in response to E2 
declined slightly with time; however, the relative percent of inhibition by APAP did not change. 
This is indicated by relatively low standard error between experiments (Table 3). 
Based upon the inhibitory effect of APAP on alkaline phosphatase determined in prior 
experiments, the final hypothesis of this study tested the ability of APAP to increase the 
inhibitory effect of antiestrogens on alkaline phosphatase activity in Ishikawa cells. Antiestrogen 
ICI 182,780, a type I pure antiestrogen, has been shown to inhibit 1nM E2 -induced alkaline 
phosphatase activity in a concentration-dependent manner (Markiewicz et al., 1997); however, in 
the present study 0.01-10µM ICI 182,780 significantly inhibited E2 -induced alkaline 
phosphatase activity below controls levels (Fig. 13) and was therefore deemed unsuitable for this 
study. 
4-Hydroxy tamoxifen is a type II antiestrogen with partial agonist activity in Ishikawa 
cells, although published reports are not consistent at this point. While some studies indicate that 
OHT alone weakly stimulates alkaline phosphatase activity (Simard et al., 1997; Anzai et al., 
1989, Markiweicz et al., 1997), cell growth (Anzai et al., 1989), and significantly inhibits E2 -
induced alkaline phosphatase activity (Simard et al., 1997; Holinka et al., 1986; Markiweicz et 
al., 1997), another study (Albert et al., 1990) found that OHT had no effect on basal or E2 -
induced alkaline phosphatase activity.  
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Results (Fig. 11) show that OHT alone decreased alkaline phosphatase activity ~50% at 
0.01, 0.1 and 1µM; cellular protein concentrations were unaffected; however, at 10µM OHT 
both alkaline phosphatase activity and protein concentrations were absent apparently due to 
toxicity. As hypothesized, APAP increased OHT inhibition of E2 -induced alkaline phosphatase 
activity (Fig. 15). While addition of 0.03APAP to 1nM E2 plus 1µM OHT had no effect (which 
agrees with previous data), addition of 0.1, 0.3 and 1mM APAP significantly increased inhibition 
of alkaline phosphatase activity in a concentration-dependent manner compared to E2 plus OHT 
alone. Cellular protein levels were significantly decreased only in cells treated with E2 plus OHT 
and 0.3, 1mM APAP. This study indicates that APAP potentiates the inhibitory effect of 
antiestrogen OHT. 
In summary, 0.01, 0.3 and 1mM APAP inhibits both basal and E2 -induced alkaline 
phosphatase activity in Ishikawa endometrial cells. In combination with antiestrogen OHT, 
APAP further inhibits E2-induced alkaline phosphatase activity. Cellular protein is significantly 
decreased in cells treated with 0.3 and 1mM APAP alone, in combination with 1nM E2, or 1nM 
E2 plus 1µM OHT. As determined by LDH release, APAP is toxic at 1mM, to a lesser degree at 
0.5mM and not at all at 0.25 compared to control. Therefore, alkaline phosphatase activity 
inhibition by 1mM APAP may be in part due to APAP-toxicity, but inhibition by 0.3 and 0.1mM 
APAP is not due to toxicity. APAP has no inhibitory effect on the specific activity of E2 -induced 
alkaline phosphatase. 
The mechanism by which APAP inhibits alkaline phosphatase activity is unknown. 
Estrogen induction of alkaline phosphatase enzyme activity in Ishikawa cells occurs via the 
classical ER mediated pathway (Fig.18). Acetaminophen does not appear to be acting through a 
traditional antiestrogenic mechanism as it does not compete with estradiol for binding at the ER 
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(Miller et al., 1999; Isenhower et al., 1986; Harnagea-Theophilusa et al., 1999) or inhibit enzyme 
activity directly. The fact that both basal and E2-inducible alkaline phosphatase enzyme activity 
is inhibited suggests that APAP may be targeting the transcription or the translational processes. 
This study did not address the question of the effect of APAP on the specific isozymes of 
alkaline phosphatase. Acetaminophen inhibits estradiol-responsive alkaline phosphatase (Fig. 5), 
but in addition, most likely inhibits the other isotypes as reflected in the inhibition of basal 
enzyme activity under serum-free (estrogen-free) conditions (Fig.7). 
A recent study demonstrated that aryl hydrocarbon receptor agonists inhibited estrogen-
induced responses through AhR-ER crosstalk in Ishikawa cells (Wormke et al., 2000). The aryl 
hydrocarbon receptor is known to be involved in the metabolism of xenobiotics; no endogenous 
ligand has been identified. The AhR contains several transactivational domains that mediate 
ligand-recognition/binding, DNA binding, AhR nuclear transport protein (ARNT) binding, as 
well as cell-specific inhibitory protein binding domain (Ma Q et al., 1997). In target cells AhR 
agonists, such as TCCD, bind the aryl hydrocarbon receptor and then complex with AhR nuclear 
transport proteins while accumulating in the nucleus of the cell (Fig. 19). This complex binds 
dioxin response elements (DREs), also known as xenobiotic response elements (XREs), and 
results in transcription of genes involved in drug and hormone metabolism such as cytochrome 
P4501A1 (CYP1A1), CYP1B1, GST, A2 and NADPH quinone reductase (Klinge et al., 1999). 
Although the AhR-ARNT complex does not bind consensus estrogen-response elements, the 
complex does bind naturally occurring EREs that contain XRE-like sequences, such as human c-
fos, pS2, and progesterone receptor gene promoter regions (Klinge et al., 1999). In transiently 
transfected MCF-7 breast cancer cells, TCDD inhibited E2-activated reporter gene activity from 
both consensus EREs and EREs from c-fos, pS2, and progesterone receptor genes (Klinge et al., 
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1999). This antiestrogenic activity by TCDD and other polycyclic hydrocarbon compounds is 
termed AhR-ER crosstalk. TCDD and other AhR ligands do not bind the ER or displace E2 from 
its receptor in ligand-binding studies (Klinge et al., 1999); however, unbound AhR directly 
interacts with ERα (Klinge et al., 2000). The AhR has no interaction with ERβ and complexed 
AhR/ARNT has no interaction with the ERα or β (Klinge et al., 2000). While the underlying 
mechanism behind AhR-ER crosstalk is not completely understood, studies indicate that there is 
direct interaction between the AhR and ER-mediated responses.  
A recent study by Wormke et al. (2000) confirms that both AhR and ARNT protein are 
expressed in Ishikawa cells. Inhibitory AhR-ER crosstalk was determined using E2-induced 
proliferation and transcriptional assays in Ishikawa cells transfected with E2-responsive 
constructs using promoters from the progesterone receptor or vitellogenin A2 genes. Aryl 
hydrocarbon receptor agonists, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), benzo[a]pyrene 
(BaP) and 6-methyl-1,3,8-trichlorodeibenzofuran, inhibited 32-47% of the E2 -induced responses 
(Wormke et al., 2000). A second study using ECC-1 endometrial cancer cells, which express 
ERα and AhR, found that treatment with TCCD also inhibited E2 -induced cell proliferation 
(Castro et al., 1999). While TCDD inhibited E2-enhanced procathespin D secretion in PE04 ER+ 
human ovarian cancer cells and Hep-1 cells (Rowlands et al., 1993; Kharat et al., 1996), in 
mutant Hep-1 cells deficient in functional AhR, TCCD was no longer inhibitory on estrogen-
inducible genes (Kharat et al., 1996). 
The results of the present study may be due to APAP binding the AhR resulting in 
inhibitory effects on E2 -responsive alkaline phosphatase activity in Ishikawa cells via an 
interaction through AhR-ER crosstalk. Although the ERE for placental alkaline phosphatase in 
Ishikawa cells has not been defined as a classical ERE, it is possible that placental alkaline 
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phosphatase, an estrogen-responsive gene, contains an XRE-like sequence. Binding of the AhR-
APAP complex to the XRE-like sequence of the promoter region of the alkaline phosphatase 
gene would block the ER from binding the ERE. This might explain the non-competitive 
inhibition of E2 -induced alkaline phosphatase activity and the inhibition of basal enzyme 
activity as well. In addition, this AhR-APAP complex could bind and inhibit other genes 
containing XRE-like sequences resulting in decreased cellular protein and possibly result in cell 
toxicity. This hypothesis also can be extended to APAP’s ability to induce cell proliferation in 
ER+/PR+ MCF7cells and inhibition of estrogen-dependent vitellogenin in trout liver cells. 
Perhaps the APAP-AhR interferes with cell cycle-regulating protein in MCF7 cells; estrogen-
dependent vitellogenin could have an XRE-like sequence in its ERE. 
 
Significance  
 
This study shows that APAP interferes with expression of estrogen-responsive genes in 
Ishikawa endometrial carcinoma cells. Even more significant was the inhibitory effect on 
estrogen-responsive alkaline phosphatase in Ishikawa cells compared to previous studies 
showing stimulation of estrogen-responsive cell proliferation in MCF-7 human breast cancer 
cells. Questions brought about by this study are two-fold: what is the mechanism behind APAP 
inhibition of alkaline phosphatase in Ishikawa cells; why does APAP have different responses in 
different cell types?  
Ishikawa cells are a good model of estrogen-responsive cells and are currently being used 
commercially as an in vitro estrogen-screen tool. The alkaline phosphatase assay is a simple and 
inexpensive assay that can be used to screen multiple samples at a time by the microplate 
method; however, the usefulness of estrogen screening by Ishikawa cells is limited and should be 
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used as an initial indicator of potential estrogenic activity. Since in vitro studies do not address 
questions such as metabolism and bioavailability of active compounds or their metabolites, 
further investigation is necessary. Whole animal and human case studies need to be utilized to 
determine actual estrogenic potential of any compound as it relates to human health. 
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Fig.18. Estrogen Receptor Mediated Gene Transcription of Alkaline Phosphatase 
and Acetaminophen interaction. The site of action of acetaminophen on alkaline 
phosphatase-induction by estradiol is unknown. Large striped arrows indicate places 
where APAP is believed not to be acting: at the ER binding site of E2; direct interaction 
with the enzyme inhibiting activity. Smaller arrows indicate places where APAP could be 
interfering with the pathway of estradiol-induction of alkaline phosphatase. 
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Fig 19. Aryl Hydrocarbon Receptor Mediated Gene Inhibition of Estrogen-Inducible 
Genes. TCDD, or other AhR agonist, enters the cell where it binds AhR. This complex binds to 
ARNTS (not depicted) as it enters the nucleus. The activated AhR-AARNT complex binds to 
xenosterogen/dioxin response elements (XRE) and also can bind EREs containing XRE-like 
sequences. AhR binding to EREs block activated estrogen receptor binding inhibiting 
transcription. Unbound AhR can bind inactive ERα in the cytosol leading to inhibition of ER 
activity. AhR-induced aryl hydrocarbon repressor (AhRR) binds AhR and serves as a self-
regulatory mechanism. 
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Future Studies 
 
Studies by Barkhem et al. (1998) indicate that OHT, raloxifene and ICI 164,384 have an 
ERα-selective partial agonist/antagonist activity, but act as pure antagonists through ERβ. 
Although there have been two subtypes of ER characterized in Ishikawa cells (Kd. 0.2 and 
0.6nM), these two ER subtypes have not been positively identified or quantified (Kassan et al., 
1989). Western blot using specific antibodies could identify ER subtypes α and β present in 
Ishikawa cells. Identification of subtypes in Ishikawa cells may also shed some light on why 
APAP has antagonist activity on alkaline phosphatase activity in Ishikawa cells, yet had 
estrogen-like activity in ER+/PR+ breast cancer cell proliferation studies. Differences in the 
presence of ER subtypes may be the reason behind the agonist or antagonist activity of APAP in  
particular cell types.  
Crosstalk between ER and AhR in Ishikawa cells, through APAP interaction with the 
AhR, is also a possible mechanism that would produce inhibition of estrogen-responsive genes. 
A recent study by Wormke et al. (2000) has shown that AhR and its associated proteins are 
expressed in Ishikawa cells. Treatment with TCDD and other AhR agonists inhibited E2-induced 
responses such cell proliferation and transcriptional activation assays (Wormke et al., 2000). 
Future experiments should be aimed at determining if APAP binds AhR in ligand-binding assays 
and if TCDD inhibits alkaline phosphatase activity in Ishikawa cells.  
It is also unclear if APAP is specifically targeting an estrogen-responsive gene or perhaps 
just targeting regulation of alkaline phosphatase. To answer this question other estrogen-
responsive genes in Ishikawa cells such as progesterone receptor induction and cell proliferation 
could be examined. If APAP were acting through an ER-mediated pathway then inhibition of 
these estrogen-regulated processes would be expected. To answer the question of APAP 
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specificity for alkaline phosphatase, T47D breast cancer cells could be used since the alkaline 
phosphatase activity expressed in that cell line is progesterone-induced and estrogen-
unresponsive (Di Lorenzo et al., 1991). The expected results would be no change in enzyme 
activity with APAP treatment in T47D cells.  
This study has evoked many questions and directions for future studies in the area of 
APAP and its interaction with estrogen-responsive genes in vitro. The studies suggested would 
enhance the understanding of ER-responsive gene regulation in estrogen-sensitive cells, as well 
as the many different possible mechanisms involved in the inhibitory process. 
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